The Golden 35 min of Stroke Intervention with ADAPT: Effect of Thrombectomy Procedural Time in Acute Ischemic Stroke on Outcome
Overview
Authors
Affiliations
Introduction: In acute ischemic stroke (AIS), extending mechanical thrombectomy procedural times beyond 60 min has previously been associated with an increased complication rate and poorer outcomes.
Objective: After improvements in thrombectomy methods, to reassess whether this relationship holds true with a more contemporary thrombectomy approach: a direct aspiration first pass technique (ADAPT).
Methods: We retrospectively studied a database of patients with AIS who underwent ADAPT thrombectomy for large vessel occlusions. Patients were dichotomized into two groups: 'early recan', in which recanalization (recan) was achieved in ≤35 min, and 'late recan', in which procedures extended beyond 35 min.
Results: 197 patients (47.7% women, mean age 66.3 years) were identified. We determined that after 35 min, a poor outcome was more likely than a good (modified Rankin Scale (mRS) score 0-2) outcome. The baseline National Institutes of Health Stroke Scale (NIHSS) score was similar between 'early recan' (n=122) (14.7±6.9) and 'late recan' patients (n=75) (15.9±7.2). Among 'early recan' patients, recanalization was achieved in 17.8±8.8 min compared with 70±39.8 min in 'late recan' patients. The likelihood of achieving a good outcome was higher in the 'early recan' group (65.2%) than in the 'late recan' group (38.2%; p<0.001). Patients in the 'late recan' group had a higher likelihood of postprocedural hemorrhage, specifically parenchymal hematoma type 2, than those in the 'early recan' group. Logistic regression analysis showed that baseline NIHSS, recanalization time, and atrial fibrillation had a significant impact on 90-day outcomes.
Conclusions: Our findings suggest that extending ADAPT thrombectomy procedure times beyond 35 min increases the likelihood of complications such as intracerebral hemorrhage while reducing the likelihood of a good outcome.
Lan W, Feng D, Qiu K, Du M, Qiu F, Xiao L J Thromb Thrombolysis. 2025; .
PMID: 40082389 DOI: 10.1007/s11239-025-03082-6.
Althobaiti F, AlQahtani M, Alharbi N, Alwadai M, Alkhatib A, Asiri M J Taibah Univ Med Sci. 2024; 19(5):1060-1066.
PMID: 39569147 PMC: 11577213. DOI: 10.1016/j.jtumed.2024.10.003.
De Mase A, Spina E, Servillo G, Barbato S, Leone G, Giordano F Interv Neuroradiol. 2024; :15910199241282714.
PMID: 39311019 PMC: 11562242. DOI: 10.1177/15910199241282714.
The differences of fibrinogen levels in various types of hemorrhagic transformations.
Long J, Chen J, Huang G, Chen Z, Zhang H, Zhang Y Front Neurol. 2024; 15:1364875.
PMID: 39119563 PMC: 11306044. DOI: 10.3389/fneur.2024.1364875.
Petrovic I, Broggi S, Killer-Oberpfalzer M, Pfaff J, Griessenauer C, Milosavljevic I Diagnostics (Basel). 2024; 14(14).
PMID: 39061668 PMC: 11275350. DOI: 10.3390/diagnostics14141531.